- Home
- WBX vs ENGN Comparison
WBX vs ENGN Comparison
Compare WBX & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WBX | ENGN |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | Spain | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.0M | 379.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WBX | ENGN |
|---|---|---|
| Price | $2.75 | $9.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $9.00 | ★ $22.71 |
| AVG Volume (30 Days) | 31.2K | ★ 280.3K |
| Earning Date | 02-26-2026 | 12-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $174,593,453.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $33.37 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.72 | $2.65 |
| 52 Week High | $14.40 | $11.14 |
Technical Indicators
Market Signals| Indicator | WBX | ENGN |
|---|---|---|
| Relative Strength Index (RSI) | 31.80 | 64.19 |
| Support Level | $2.88 | $7.57 |
| Resistance Level | $3.36 | $8.47 |
| Average True Range (ATR) | 0.22 | 0.73 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 3.74 | 74.31 |
Price Performance
Historical ComparisonAbout WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.